APO RESEARCH · REPORT
DNA Vaccines
The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.
Product & engineering
Understand the product.
The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.
Selected research
Industry Research
DNA Vaccines Industry Research Report 2026
Market perspective
The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.
Global direct-to-consumer genetic testing main players include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals and Plumbline Life Sciences, etc., totally accounting for about 50% of the market. North America is the largest market, with a share over 95%. As for the types of products, it can be divided into recombinant protein vaccine and gene-based vaccine. The most common product is recombinant protein, with a share over 95%. In terms of applications, it is widely used in human and animal. Human is the largest application, holding a share over 95%.
Report Scope
Read the full market overview
This report quantifies the global DNA Vaccines market in terms of revenue (US$ million) and, where applicable, sales volume (K Doses), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Doses) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
DNA Vaccines Market by Company
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
DNA Vaccines Segment by Type
Recombinant Protein Vaccine
Gene-Based Vaccine
DNA Vaccines Segment by Application
Human
Animal
DNA Vaccines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DNA Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of DNA Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of DNA Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of DNA Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Recombinant Protein Vaccine
- Gene-Based Vaccine
Applications
- Human
- Animal
Companies covered
- Merck
- GSK
- Sanofi
- Zoties
- Elanco
- Boehringer-Ingelheim
- Indian Immunologicals
- Plumbline Life Sciences
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global DNA Vaccines Market Size (2021-2032)
- 2.2.2 Global DNA Vaccines Sales (2021-2032)
- 2.2.3 Global DNA Vaccines Market Average Price (2021-2032)
- 2.3 DNA Vaccines by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Recombinant Protein Vaccine
- 2.3.3 Gene-Based Vaccine
- 2.4 DNA Vaccines by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Human
- 2.4.3 Animal
3 Market Competitive Landscape by Manufacturers
- 3.1 Global DNA Vaccines Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global DNA Vaccines Sales (K Doses) of Manufacturers (2021-2026)
- 3.3 Global DNA Vaccines Revenue of Manufacturers (2021-2026)
- 3.4 Global DNA Vaccines Average Price by Manufacturers (2021-2026)
- 3.5 Global DNA Vaccines Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of DNA Vaccines, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of DNA Vaccines, Product Type & Application
- 3.8 Global Manufacturers of DNA Vaccines, Established Date
- 3.9 Global DNA Vaccines Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Merck
- 4.1.1 Merck Company Information
- 4.1.2 Merck Business Overview
- 4.1.3 Merck DNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Merck DNA Vaccines Product Portfolio
- 4.1.5 Merck Recent Developments
- 4.2 GSK
- 4.2.1 GSK Company Information
- 4.2.2 GSK Business Overview
- 4.2.3 GSK DNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 GSK DNA Vaccines Product Portfolio
- 4.2.5 GSK Recent Developments
- 4.3 Sanofi
- 4.3.1 Sanofi Company Information
- 4.3.2 Sanofi Business Overview
- 4.3.3 Sanofi DNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sanofi DNA Vaccines Product Portfolio
- 4.3.5 Sanofi Recent Developments
- 4.4 Zoties
- 4.4.1 Zoties Company Information
- 4.4.2 Zoties Business Overview
- 4.4.3 Zoties DNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Zoties DNA Vaccines Product Portfolio
- 4.4.5 Zoties Recent Developments
- 4.5 Elanco
- 4.5.1 Elanco Company Information
- 4.5.2 Elanco Business Overview
- 4.5.3 Elanco DNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Elanco DNA Vaccines Product Portfolio
- 4.5.5 Elanco Recent Developments
- 4.6 Boehringer-Ingelheim
- 4.6.1 Boehringer-Ingelheim Company Information
- 4.6.2 Boehringer-Ingelheim Business Overview
- 4.6.3 Boehringer-Ingelheim DNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Boehringer-Ingelheim DNA Vaccines Product Portfolio
- 4.6.5 Boehringer-Ingelheim Recent Developments
- 4.7 Indian Immunologicals
- 4.7.1 Indian Immunologicals Company Information
- 4.7.2 Indian Immunologicals Business Overview
- 4.7.3 Indian Immunologicals DNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Indian Immunologicals DNA Vaccines Product Portfolio
- 4.7.5 Indian Immunologicals Recent Developments
- 4.8 Plumbline Life Sciences
- 4.8.1 Plumbline Life Sciences Company Information
- 4.8.2 Plumbline Life Sciences Business Overview
- 4.8.3 Plumbline Life Sciences DNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Plumbline Life Sciences DNA Vaccines Product Portfolio
- 4.8.5 Plumbline Life Sciences Recent Developments
5 Global DNA Vaccines Market Scenario by Region
- 5.1 Global DNA Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global DNA Vaccines Sales by Region: 2021-2032
- 5.2.1 Global DNA Vaccines Sales by Region: 2021-2026
- 5.2.2 Global DNA Vaccines Sales by Region: 2027-2032
- 5.3 Global DNA Vaccines Revenue by Region: 2021-2032
- 5.3.1 Global DNA Vaccines Revenue by Region: 2021-2026
- 5.3.2 Global DNA Vaccines Revenue by Region: 2027-2032
- 5.4 North America DNA Vaccines Market Facts & Figures by Country
- 5.4.1 North America DNA Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America DNA Vaccines Sales by Country (2021-2032)
- 5.4.3 North America DNA Vaccines Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe DNA Vaccines Market Facts & Figures by Country
- 5.5.1 Europe DNA Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe DNA Vaccines Sales by Country (2021-2032)
- 5.5.3 Europe DNA Vaccines Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific DNA Vaccines Market Facts & Figures by Country
- 5.6.1 Asia Pacific DNA Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific DNA Vaccines Sales by Country (2021-2032)
- 5.6.3 Asia Pacific DNA Vaccines Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America DNA Vaccines Market Facts & Figures by Country
- 5.7.1 South America DNA Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America DNA Vaccines Sales by Country (2021-2032)
- 5.7.3 South America DNA Vaccines Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa DNA Vaccines Market Facts & Figures by Country
- 5.8.1 Middle East and Africa DNA Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa DNA Vaccines Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa DNA Vaccines Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global DNA Vaccines Sales by Type (2021-2032)
- 6.1.1 Global DNA Vaccines Sales by Type (2021-2032) & (K Doses)
- 6.1.2 Global DNA Vaccines Sales Market Share by Type (2021-2032)
- 6.2 Global DNA Vaccines Revenue by Type (2021-2032)
- 6.2.1 Global DNA Vaccines Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global DNA Vaccines Revenue Market Share by Type (2021-2032)
- 6.3 Global DNA Vaccines Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global DNA Vaccines Sales by Application (2021-2032)
- 7.1.1 Global DNA Vaccines Sales by Application (2021-2032) & (K Doses)
- 7.1.2 Global DNA Vaccines Sales Market Share by Application (2021-2032)
- 7.2 Global DNA Vaccines Revenue by Application (2021-2032)
- 7.2.1 Global DNA Vaccines Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global DNA Vaccines Revenue Market Share by Application (2021-2032)
- 7.3 Global DNA Vaccines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 DNA Vaccines Value Chain Analysis
- 8.1.1 DNA Vaccines Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 DNA Vaccines Production Mode & Process
- 8.2 DNA Vaccines Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 DNA Vaccines Distributors
- 8.2.3 DNA Vaccines Customers
9 Global DNA Vaccines Analyzing Market Dynamics
- 9.1 DNA Vaccines Industry Trends
- 9.2 DNA Vaccines Industry Drivers
- 9.3 DNA Vaccines Industry Opportunities and Challenges
- 9.4 DNA Vaccines Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst